ArticleScientific reports2023

In silico and in vitro studies confirm Ondansetron as a novel acetylcholinesterase and butyrylcholinesterase inhibitor.

Asma Gholami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.